Total amount: € 0,00
Cameli N., Mariano M.
Istituto Dermatologico San Gallicano, IRCCS, Roma, Italia
New therapeutic protocols in oncology have led to an increasing survival rate accompanied by a growth in the incidence of cutaneous side effects and a worsening of patients’ quality of life. Appropriate management of skin toxicity associated with chemotherapic agents is therefore necessary for suitable drug administration and to improve quality of life and clinical outcomes. An outpatient department for the skin care of oncological patients has been founded in San Gallicano Dermatological Institute in collaboration with the Miller School of Medicine University of Miami and the University of Naples Federico II and San Camillo Forlanini Hospital of Rome, as part of the project “Il Corpo Ritrovato”. We have clinically examined 400 patients affected by cancer, determining type, frequency, treatment, and evolution of side effects related to chemotherapy.